Transient elastography: A non-invasive tool for assessing liver fibrosis in HIV/HCV patients

Table 4 Estimates of liver fibrosis using biochemical markers and transient elastography, mean (range)

	HIV (n = 71)	HCV (n = 53)	HIV/HCV (n = 57)
APRI	0.31 (0.1-1.6)ab	0.93 (0.28-6.07)	0.92 (0.17-19.7)
FIB-4	0.93 (0.39-4.28)a	1.62 (0.47-12.6)	1.63 (0.63-23.8)
LS	5.4 (3.2-26.6)ab	7.3 (3.4-40.9)c	9.8 (4.3-48.8)

^aP < 0.0001 vs hepatitis C virus (HCV);

^bP < 0.0001,

^cP < 0.05 vs human immunodeficiency virus (HIV)/HCV. LS: Liver stiffness; APRI: Aspartate aminotransferase platelet ratio index.